177 related articles for article (PubMed ID: 9951525)
1. Probing the disulfide folding pathway of insulin-like growth factor-I.
Milner SJ; Carver JA; Ballard FJ; Francis GL
Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525
[TBL] [Abstract][Full Text] [Related]
2. Putative folding pathway of insulin-like growth factor-I.
Rosenfeld RD; Miller JA; Narhi LO; Hawkins N; Katta V; Lauren S; Weiss MA; Arakawa T
Arch Biochem Biophys; 1997 Jun; 342(2):298-305. PubMed ID: 9186491
[TBL] [Abstract][Full Text] [Related]
3. Native and non-native structure in a protein-folding intermediate: spectroscopic studies of partially reduced IGF-I and an engineered alanine model.
Hua QX; Narhi L; Jia W; Arakawa T; Rosenfeld R; Hawkins N; Miller JA; Weiss MA
J Mol Biol; 1996 Jun; 259(2):297-313. PubMed ID: 8656430
[TBL] [Abstract][Full Text] [Related]
4. Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro.
Hober S; Uhlén M; Nilsson B
Biochemistry; 1997 Apr; 36(15):4616-22. PubMed ID: 9109671
[TBL] [Abstract][Full Text] [Related]
5. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
Chen Y; You Y; Jin R; Guo ZY; Feng YM
Biochemistry; 2004 Jul; 43(28):9225-33. PubMed ID: 15248780
[TBL] [Abstract][Full Text] [Related]
6. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1.
Wang S; Guo ZY; Shen L; Zhang YJ; Feng YM
Biochemistry; 2003 Aug; 42(32):9687-93. PubMed ID: 12911310
[TBL] [Abstract][Full Text] [Related]
7. Direct identification of a novel disulfide bond linkage system of new isolated isomer (isomer V) in recombinantly produced h-IGF-I.
Iwai M; Yokoyama H; Yamada H; Niwa M; Kobayashi M
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1304-9. PubMed ID: 10993229
[TBL] [Abstract][Full Text] [Related]
8. Development of an optimized refolding process for recombinant Ala-Glu-IGF-1.
Hejnaes KR; Bayne S; Nørskov L; Sørensen HH; Thomsen J; Schäffer L; Wollmer A; Skriver L
Protein Eng; 1992 Dec; 5(8):797-806. PubMed ID: 1287661
[TBL] [Abstract][Full Text] [Related]
9. [Oxidative refolding of proteins].
Zhang YY; Yang KY
Sheng Wu Gong Cheng Xue Bao; 2003 Jan; 19(1):1-8. PubMed ID: 15969027
[TBL] [Abstract][Full Text] [Related]
10. Direct identification of disulfide bond linkages in human insulin-like growth factor I (IGF-I) by chemical synthesis.
Iwai M; Kobayashi M; Tamura K; Ishii Y; Yamada H; Niwa M
J Biochem; 1989 Dec; 106(6):949-51. PubMed ID: 2628430
[TBL] [Abstract][Full Text] [Related]
11. The sequence determinant causing different folding behaviors of insulin and insulin-like growth factor-1.
Huang QL; Zhao J; Tang YH; Shao SQ; Xu GJ; Feng YM
Biochemistry; 2007 Jan; 46(1):218-24. PubMed ID: 17198392
[TBL] [Abstract][Full Text] [Related]
12. Role of disulfide bonds for the structure and folding of proguanylin.
Lauber T; Schulz A; Rösch P; Marx UC
Biochemistry; 2004 Aug; 43(31):10050-7. PubMed ID: 15287732
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional solution structure of a disulfide bond isomer of the human insulin-like growth factor-I.
Sato A; Koyama S; Yamada H; Suzuki S; Tamura K; Kobayashi M; Niwa M; Yasuda T; Kyogoku Y; Kobayashi Y
J Pept Res; 2000 Oct; 56(4):218-30. PubMed ID: 11083061
[TBL] [Abstract][Full Text] [Related]
14. 1.42A crystal structure of mini-IGF-1(2): an analysis of the disulfide isomerization property and receptor binding property of IGF-1 based on the three-dimensional structure.
Yun CH; Tang YH; Feng YM; An XM; Chang WR; Liang DC
Biochem Biophys Res Commun; 2005 Jan; 326(1):52-9. PubMed ID: 15567151
[TBL] [Abstract][Full Text] [Related]
15. Conformational exchange is critical for the productivity of an oxidative folding intermediate with buried free cysteines.
Gross G; Gallopin M; Vandame M; Couprie J; Stura E; Zinn-Justin S; Drevet P
J Mol Biol; 2010 Oct; 403(2):299-312. PubMed ID: 20804768
[TBL] [Abstract][Full Text] [Related]
16. Major kinetic traps for the oxidative folding of leech carboxypeptidase inhibitor.
Salamanca S; Li L; Vendrell J; Aviles FX; Chang JY
Biochemistry; 2003 Jun; 42(22):6754-61. PubMed ID: 12779330
[TBL] [Abstract][Full Text] [Related]
17. Disulfide arrangement of human insulin-like growth factor I derived from yeast and plasma.
Axelsson K; Johansson S; Eketorp G; Zazzi H; Hemmendorf B; Gellerfors P
Eur J Biochem; 1992 Jun; 206(3):987-94. PubMed ID: 1606975
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.
Milner SJ; Francis GL; Wallace JC; Magee BA; Ballard FJ
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):865-71. PubMed ID: 8948444
[TBL] [Abstract][Full Text] [Related]
19. Binding protein, radioreceptor and biological activities of recombinant methionyl insulin-like growth factor-I variants.
Hodgkinson SC; Napier JR; Davis SR; Patel B; Gluckman PD
Mol Cell Endocrinol; 1989 Sep; 66(1):37-44. PubMed ID: 2479583
[TBL] [Abstract][Full Text] [Related]
20. Pathway of oxidative folding of secretory leucocyte protease inhibitor: an 8-disulfide protein exhibits a unique mechanism of folding.
Lin CC; Chang JY
Biochemistry; 2006 May; 45(19):6231-40. PubMed ID: 16681396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
